Contribution: SIF Stream2- Growth
Precision NanoSystems ULC
$3,522,703.00
Biomanufacturing Centre Project.
FY 2020-21 · 2020-06-01
Summary
This project aimed to establish Canada’s first end-to-end manufacturing of genetic medicines for the production of nanomedicine-based RNA vaccines, gene therapies and cell therapies.
Program
SIF Stream2- Growth
Recipient
Location
Vancouver, British Columbia, Canada
Recipient Type
For-profit organization
Business Number
851285114
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Amendments
Each version of the agreement as published, oldest first, with its total as of that version. The amount above is the latest.
| Amendment | Date | Fiscal Year | Total |
|---|---|---|---|
| 0 | 2020-06-01 | 2020-21 | $25,112,000.00 |
| 1 | 2020-06-01 | 2020-21 | $25,112,000.00 |
| 2 | 2020-06-01 | 2020-21 | $3,522,703.00 |
As published
Additional Information
The amendment has been completed to terminate the contribution agreement by mutual consent.
Additional Information (French)
L'amendement a été complété pour mettre fin à l’entente de contribution par consentement mutuel.
Agreement End Date
2025-03-26
Agreement Number
815823
Agreement Start Date
2020-06-01
Agreement Title
Biomanufacturing Centre Project.
Agreement Title (French)
Projet de centre de biofabrication
Agreement Type
Contribution
Agreement Value
$3,522,703.00
Amendment Date
2024-03-26
Amendment Number
2
Description
This project aimed to establish Canada’s first end-to-end manufacturing of genetic medicines for the production of nanomedicine-based RNA vaccines, gene therapies and cell therapies.
Description (French)
Ce projet visait à établir la première fabrication de bout en bout de médicaments génétiques au Canada pour la production de vaccins à ARN, de thérapies géniques et de thérapies cellulaires basées sur la nanomédecine.
Expected Results
The biomanufacturing project was to allow PNU to expand their ability to produce ribonucleic acid vaccines and future genetic medicines in Canada.
Expected Results (French)
Le projet de biofabrication devait permettre à PNU d'étendre sa capacité à produire des vaccins à base d'acide ribonucléique et de futurs médicaments génétiques au Canada.
Federal Riding
Vancouver Granville
Federal Riding (French)
Vancouver Granville
Federal Riding Number
59036
NAICS Code
541710
Organization Code
ic
Organization
Innovation, Science and Economic Development Canada | Innovation, Sciences et Développement économique Canada
Program Name
SIF Stream2- Growth
Program Name (French)
FIS Volet 2- Croissance
Program Purpose
-Encourage R&D that will accelerate technology transfer and commercialization of innovative products, processes and services;-Facilitate the growth and expansion of firms in Canada;-Attract and retain large scale investments to Canada; and-Advance industrial research, development and technology demonstration through collaboration between academia, non-profit organizations and the private sector.
Program Purpose (French)
-favoriser les activités de R-D qui accéléreront le transfert de la technologie et la commercialisation de produits, de processus et de services novateurs ;-faciliter la croissance et l'expansion des entreprises au Canada ;-attirer et conserver des investissements de grande envergure au Canada ; et-faire progresser la recherche industrielle, le développement et la démonstration de technologies grâce à la collaboration entre les universitaires, les organisations à but non lucratif et le secteur privé.
Recipient Business Number
851285114
Recipient City
Vancouver
Recipient Country
CA
Recipient Legal Name
Precision NanoSystems ULC
Recipient Operating Name
Precision NanoSystems ULC
Recipient Postal Code
V6P6T7
Recipient Province or Territory
BC
Recipient Type
F
Reference Number
033-2020-2021-Q4-815823
